EBITDA: Income before interest, taxes, depreciation and amortization.
Spruce Biosciences, Inc. (SPRB) had EBITDA of $-11.73M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-12.27M |
|
-- |
|
-- |
|
$11.99M |
|
$-11.99M |
|
$-0.28M |
|
$-12.27M |
|
$-12.27M |
|
$-12.27M |
|
$-12.27M |
|
$-12.27M |
|
$-12.27M |
|
$-11.99M |
|
|
EBITDA |
$-11.73M |
1.37M |
|
1.37M |
|
$-8.94 |
|
$-8.94 |
|
| Balance Sheet Financials | |
$55.03M |
|
-- |
|
$1.13M |
|
$56.17M |
|
$11.78M |
|
$5.46M |
|
$9.73M |
|
$21.52M |
|
$34.65M |
|
$34.65M |
|
$34.65M |
|
1.37M |
|
| Cash Flow Statement Financials | |
$-8.73M |
|
$-0.01M |
|
$13.92M |
|
$48.94M |
|
$54.12M |
|
$5.17M |
|
$0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.67 |
|
-- |
|
-- |
|
0.14 |
|
0.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.40% |
|
-35.40% |
|
-21.84% |
|
-30.58% |
|
$25.25 |
|
$-6.37 |
|
$-6.36 |
|